The study of neuroprotective effects and underlying mechanism of Naoshuantong capsule on ischemia stroke mice

Background Naoshuantong capsule (NSTC) is an oral Chinese medicine formula composed of Typhae Pollen, Radix Paeoniae Rubra, Curcumae Radix, Gastrodiae Rhizoma and Radix Rhapontici. It has been widely used at the acute and recovery stage of ischemic stroke since 2001. Comparing with its wide clinical...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chinese medicine 2020-11, Vol.15 (1), p.1-119, Article 119
Hauptverfasser: Luo, Lvkeng, Wu, Shuling, Chen, Ruiqi, Rao, Hongyu, Peng, Wei, Su, Weiwei
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 119
container_issue 1
container_start_page 1
container_title Chinese medicine
container_volume 15
creator Luo, Lvkeng
Wu, Shuling
Chen, Ruiqi
Rao, Hongyu
Peng, Wei
Su, Weiwei
description Background Naoshuantong capsule (NSTC) is an oral Chinese medicine formula composed of Typhae Pollen, Radix Paeoniae Rubra, Curcumae Radix, Gastrodiae Rhizoma and Radix Rhapontici. It has been widely used at the acute and recovery stage of ischemic stroke since 2001. Comparing with its wide clinical application, there are only few studies emphasize on investigating its pharmacological effects. Methods To more generally elucidate the underlying mechanisms in this study, we identified active ingredients in NSTC by a network pharmacology approach based on transcriptomics analysis and pharmacological experiments. Modified neurological severity scores and morphometric analysis using Nissl staining were employed to evaluate the neuroprotective effects of NSTC on ischemia stroke in mice. Results The results showed that NSTC had preventive and protective effects on ischemia stroke, featuring repair of brain tissue during the sub-acute stage of stroke. This may attribute to the underlying mechanisms including anti-inflammatory, antioxidant, and anti-apoptotic activities, as well as an attenuation of excitatory amino acids (EAAs) toxicity of the active ingredients, especially the most active apigenin, from NSTC. Specifically, naringenin, calycosin, gastrodin, caffeic acid, paeoniflorin, and beta-elemene seem to be also pharmacological active substances responsible for the anti-inflammatory effects. Meanwhile, 13-hydroxygemone, gastrodin, and p-hydroxybenzyl alcohol contributed to the attenuation of EAAs toxicity Furthermore, apigenin, naringenin, calycosin, gastrodin, and beta-elemene accelerated the repair of brain ischemic tissue by up-regulating the expression of TGF-beta 1 levels. Conclusions The present study identifies the active ingredients of NSTC and illustrates the underlying mechanism using a combination of network pharmacology, transcriptomics analysis, and pharmacological experiments.
doi_str_mv 10.1186/s13020-020-00399-7
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2468675050</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A642286986</galeid><doaj_id>oai_doaj_org_article_812274ae23d14331871cb3edd2ffdbd5</doaj_id><sourcerecordid>A642286986</sourcerecordid><originalsourceid>FETCH-LOGICAL-c571t-1bd0131bd5436937a04994e72cbca41ead65b057a7a415a3c92e4d17ce4ab4b03</originalsourceid><addsrcrecordid>eNqNkl2L1DAUhoso7jr6B7wqCCJI13y1aW6EZfBjYdGb9Tqkyek0Y5uMSbrL_HvTmWXdES9sSXqaPO_b05NTFK8xusC4bT5ETBFB1WEgKkTFnxTnmDNRtTVrnj6Kz4oXMW4RqmlN2-fFGaVEEErFeTHdDFDGNJt96fvSwRz8LvgEOtlbKKHvcxRL5Uw5OwNh3Fu3KSfQg3I2Tovmm_JxmJVLPu9otYvzCKV3pY16gMmq7B78Tygnq-Fl8axXY4RX989V8ePzp5v11-r6-5er9eV1pWuOU4U7gzDNc81oIyhXiAnBgBPdacUwKNPUHaq54vmtVlQLAsxgroGpjnWIroqro6_xait3wU4q7KVXVh4WfNhIFZLVI8gWE8KZAkINZpTilmPdUTCG9L3JGWSvj0ev3dxNYDS4FNR4Ynq64-wgN_5W8oajRizJvLs3CP7XDDHJKdcGxlE58HOUhDVtw2tUL-ibv9Ctn4PLpVoo3GJcM_6H2qj8A9b1Pn9XL6bysmGEtI1om0xd_IPKt8mnor2D3ub1E8HbR4IB1JiG6Mc5We_iKUiOoA4-xgD9QzEwkktnymNnysNYOlMuSb8_iu6g833UFpyGByHKvdmKfNEc5bNfFe3_02ub1JLk2s8u0d_9Z_VM</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2461811547</pqid></control><display><type>article</type><title>The study of neuroprotective effects and underlying mechanism of Naoshuantong capsule on ischemia stroke mice</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>SpringerNature Journals</source><source>PubMed Central Open Access</source><source>Web of Science - Science Citation Index Expanded - 2020&lt;img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /&gt;</source><source>PubMed Central</source><source>Springer Nature OA/Free Journals</source><creator>Luo, Lvkeng ; Wu, Shuling ; Chen, Ruiqi ; Rao, Hongyu ; Peng, Wei ; Su, Weiwei</creator><creatorcontrib>Luo, Lvkeng ; Wu, Shuling ; Chen, Ruiqi ; Rao, Hongyu ; Peng, Wei ; Su, Weiwei</creatorcontrib><description>Background Naoshuantong capsule (NSTC) is an oral Chinese medicine formula composed of Typhae Pollen, Radix Paeoniae Rubra, Curcumae Radix, Gastrodiae Rhizoma and Radix Rhapontici. It has been widely used at the acute and recovery stage of ischemic stroke since 2001. Comparing with its wide clinical application, there are only few studies emphasize on investigating its pharmacological effects. Methods To more generally elucidate the underlying mechanisms in this study, we identified active ingredients in NSTC by a network pharmacology approach based on transcriptomics analysis and pharmacological experiments. Modified neurological severity scores and morphometric analysis using Nissl staining were employed to evaluate the neuroprotective effects of NSTC on ischemia stroke in mice. Results The results showed that NSTC had preventive and protective effects on ischemia stroke, featuring repair of brain tissue during the sub-acute stage of stroke. This may attribute to the underlying mechanisms including anti-inflammatory, antioxidant, and anti-apoptotic activities, as well as an attenuation of excitatory amino acids (EAAs) toxicity of the active ingredients, especially the most active apigenin, from NSTC. Specifically, naringenin, calycosin, gastrodin, caffeic acid, paeoniflorin, and beta-elemene seem to be also pharmacological active substances responsible for the anti-inflammatory effects. Meanwhile, 13-hydroxygemone, gastrodin, and p-hydroxybenzyl alcohol contributed to the attenuation of EAAs toxicity Furthermore, apigenin, naringenin, calycosin, gastrodin, and beta-elemene accelerated the repair of brain ischemic tissue by up-regulating the expression of TGF-beta 1 levels. Conclusions The present study identifies the active ingredients of NSTC and illustrates the underlying mechanism using a combination of network pharmacology, transcriptomics analysis, and pharmacological experiments.</description><identifier>ISSN: 1749-8546</identifier><identifier>EISSN: 1749-8546</identifier><identifier>DOI: 10.1186/s13020-020-00399-7</identifier><identifier>PMID: 33292339</identifier><language>eng</language><publisher>LONDON: Springer Nature</publisher><subject>Acids ; Amino acids ; Analysis ; Antioxidants ; Apoptosis ; Caffeic acid ; Chinese medicine ; Ethanol ; Excitatory amino acids ; FDA approval ; Inflammation ; Integrative &amp; Complementary Medicine ; Ischemia ; Laboratory animals ; Life Sciences &amp; Biomedicine ; Mice ; Morphometry ; Naoshuantong capsule ; Naringenin ; Network pharmacology ; Neuroprotection ; Neuroprotective ; Pharmacology ; Pharmacology &amp; Pharmacy ; Proteins ; Science &amp; Technology ; Software ; Solvents ; Stroke ; Toxicity ; Transforming growth factor-b1 ; Transforming growth factors</subject><ispartof>Chinese medicine, 2020-11, Vol.15 (1), p.1-119, Article 119</ispartof><rights>COPYRIGHT 2020 BioMed Central Ltd.</rights><rights>2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>14</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000589999300001</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c571t-1bd0131bd5436937a04994e72cbca41ead65b057a7a415a3c92e4d17ce4ab4b03</citedby><cites>FETCH-LOGICAL-c571t-1bd0131bd5436937a04994e72cbca41ead65b057a7a415a3c92e4d17ce4ab4b03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670690/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670690/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,865,886,2103,2115,27929,27930,28253,53796,53798</link.rule.ids></links><search><creatorcontrib>Luo, Lvkeng</creatorcontrib><creatorcontrib>Wu, Shuling</creatorcontrib><creatorcontrib>Chen, Ruiqi</creatorcontrib><creatorcontrib>Rao, Hongyu</creatorcontrib><creatorcontrib>Peng, Wei</creatorcontrib><creatorcontrib>Su, Weiwei</creatorcontrib><title>The study of neuroprotective effects and underlying mechanism of Naoshuantong capsule on ischemia stroke mice</title><title>Chinese medicine</title><addtitle>CHIN MED-UK</addtitle><description>Background Naoshuantong capsule (NSTC) is an oral Chinese medicine formula composed of Typhae Pollen, Radix Paeoniae Rubra, Curcumae Radix, Gastrodiae Rhizoma and Radix Rhapontici. It has been widely used at the acute and recovery stage of ischemic stroke since 2001. Comparing with its wide clinical application, there are only few studies emphasize on investigating its pharmacological effects. Methods To more generally elucidate the underlying mechanisms in this study, we identified active ingredients in NSTC by a network pharmacology approach based on transcriptomics analysis and pharmacological experiments. Modified neurological severity scores and morphometric analysis using Nissl staining were employed to evaluate the neuroprotective effects of NSTC on ischemia stroke in mice. Results The results showed that NSTC had preventive and protective effects on ischemia stroke, featuring repair of brain tissue during the sub-acute stage of stroke. This may attribute to the underlying mechanisms including anti-inflammatory, antioxidant, and anti-apoptotic activities, as well as an attenuation of excitatory amino acids (EAAs) toxicity of the active ingredients, especially the most active apigenin, from NSTC. Specifically, naringenin, calycosin, gastrodin, caffeic acid, paeoniflorin, and beta-elemene seem to be also pharmacological active substances responsible for the anti-inflammatory effects. Meanwhile, 13-hydroxygemone, gastrodin, and p-hydroxybenzyl alcohol contributed to the attenuation of EAAs toxicity Furthermore, apigenin, naringenin, calycosin, gastrodin, and beta-elemene accelerated the repair of brain ischemic tissue by up-regulating the expression of TGF-beta 1 levels. Conclusions The present study identifies the active ingredients of NSTC and illustrates the underlying mechanism using a combination of network pharmacology, transcriptomics analysis, and pharmacological experiments.</description><subject>Acids</subject><subject>Amino acids</subject><subject>Analysis</subject><subject>Antioxidants</subject><subject>Apoptosis</subject><subject>Caffeic acid</subject><subject>Chinese medicine</subject><subject>Ethanol</subject><subject>Excitatory amino acids</subject><subject>FDA approval</subject><subject>Inflammation</subject><subject>Integrative &amp; Complementary Medicine</subject><subject>Ischemia</subject><subject>Laboratory animals</subject><subject>Life Sciences &amp; Biomedicine</subject><subject>Mice</subject><subject>Morphometry</subject><subject>Naoshuantong capsule</subject><subject>Naringenin</subject><subject>Network pharmacology</subject><subject>Neuroprotection</subject><subject>Neuroprotective</subject><subject>Pharmacology</subject><subject>Pharmacology &amp; Pharmacy</subject><subject>Proteins</subject><subject>Science &amp; Technology</subject><subject>Software</subject><subject>Solvents</subject><subject>Stroke</subject><subject>Toxicity</subject><subject>Transforming growth factor-b1</subject><subject>Transforming growth factors</subject><issn>1749-8546</issn><issn>1749-8546</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>AOWDO</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>DOA</sourceid><recordid>eNqNkl2L1DAUhoso7jr6B7wqCCJI13y1aW6EZfBjYdGb9Tqkyek0Y5uMSbrL_HvTmWXdES9sSXqaPO_b05NTFK8xusC4bT5ETBFB1WEgKkTFnxTnmDNRtTVrnj6Kz4oXMW4RqmlN2-fFGaVEEErFeTHdDFDGNJt96fvSwRz8LvgEOtlbKKHvcxRL5Uw5OwNh3Fu3KSfQg3I2Tovmm_JxmJVLPu9otYvzCKV3pY16gMmq7B78Tygnq-Fl8axXY4RX989V8ePzp5v11-r6-5er9eV1pWuOU4U7gzDNc81oIyhXiAnBgBPdacUwKNPUHaq54vmtVlQLAsxgroGpjnWIroqro6_xait3wU4q7KVXVh4WfNhIFZLVI8gWE8KZAkINZpTilmPdUTCG9L3JGWSvj0ev3dxNYDS4FNR4Ynq64-wgN_5W8oajRizJvLs3CP7XDDHJKdcGxlE58HOUhDVtw2tUL-ibv9Ctn4PLpVoo3GJcM_6H2qj8A9b1Pn9XL6bysmGEtI1om0xd_IPKt8mnor2D3ub1E8HbR4IB1JiG6Mc5We_iKUiOoA4-xgD9QzEwkktnymNnysNYOlMuSb8_iu6g833UFpyGByHKvdmKfNEc5bNfFe3_02ub1JLk2s8u0d_9Z_VM</recordid><startdate>20201117</startdate><enddate>20201117</enddate><creator>Luo, Lvkeng</creator><creator>Wu, Shuling</creator><creator>Chen, Ruiqi</creator><creator>Rao, Hongyu</creator><creator>Peng, Wei</creator><creator>Su, Weiwei</creator><general>Springer Nature</general><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>AOWDO</scope><scope>BLEPL</scope><scope>DTL</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20201117</creationdate><title>The study of neuroprotective effects and underlying mechanism of Naoshuantong capsule on ischemia stroke mice</title><author>Luo, Lvkeng ; Wu, Shuling ; Chen, Ruiqi ; Rao, Hongyu ; Peng, Wei ; Su, Weiwei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c571t-1bd0131bd5436937a04994e72cbca41ead65b057a7a415a3c92e4d17ce4ab4b03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Acids</topic><topic>Amino acids</topic><topic>Analysis</topic><topic>Antioxidants</topic><topic>Apoptosis</topic><topic>Caffeic acid</topic><topic>Chinese medicine</topic><topic>Ethanol</topic><topic>Excitatory amino acids</topic><topic>FDA approval</topic><topic>Inflammation</topic><topic>Integrative &amp; Complementary Medicine</topic><topic>Ischemia</topic><topic>Laboratory animals</topic><topic>Life Sciences &amp; Biomedicine</topic><topic>Mice</topic><topic>Morphometry</topic><topic>Naoshuantong capsule</topic><topic>Naringenin</topic><topic>Network pharmacology</topic><topic>Neuroprotection</topic><topic>Neuroprotective</topic><topic>Pharmacology</topic><topic>Pharmacology &amp; Pharmacy</topic><topic>Proteins</topic><topic>Science &amp; Technology</topic><topic>Software</topic><topic>Solvents</topic><topic>Stroke</topic><topic>Toxicity</topic><topic>Transforming growth factor-b1</topic><topic>Transforming growth factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Luo, Lvkeng</creatorcontrib><creatorcontrib>Wu, Shuling</creatorcontrib><creatorcontrib>Chen, Ruiqi</creatorcontrib><creatorcontrib>Rao, Hongyu</creatorcontrib><creatorcontrib>Peng, Wei</creatorcontrib><creatorcontrib>Su, Weiwei</creatorcontrib><collection>Web of Science - Science Citation Index Expanded - 2020</collection><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Proquest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Chinese medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Luo, Lvkeng</au><au>Wu, Shuling</au><au>Chen, Ruiqi</au><au>Rao, Hongyu</au><au>Peng, Wei</au><au>Su, Weiwei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The study of neuroprotective effects and underlying mechanism of Naoshuantong capsule on ischemia stroke mice</atitle><jtitle>Chinese medicine</jtitle><stitle>CHIN MED-UK</stitle><date>2020-11-17</date><risdate>2020</risdate><volume>15</volume><issue>1</issue><spage>1</spage><epage>119</epage><pages>1-119</pages><artnum>119</artnum><issn>1749-8546</issn><eissn>1749-8546</eissn><abstract>Background Naoshuantong capsule (NSTC) is an oral Chinese medicine formula composed of Typhae Pollen, Radix Paeoniae Rubra, Curcumae Radix, Gastrodiae Rhizoma and Radix Rhapontici. It has been widely used at the acute and recovery stage of ischemic stroke since 2001. Comparing with its wide clinical application, there are only few studies emphasize on investigating its pharmacological effects. Methods To more generally elucidate the underlying mechanisms in this study, we identified active ingredients in NSTC by a network pharmacology approach based on transcriptomics analysis and pharmacological experiments. Modified neurological severity scores and morphometric analysis using Nissl staining were employed to evaluate the neuroprotective effects of NSTC on ischemia stroke in mice. Results The results showed that NSTC had preventive and protective effects on ischemia stroke, featuring repair of brain tissue during the sub-acute stage of stroke. This may attribute to the underlying mechanisms including anti-inflammatory, antioxidant, and anti-apoptotic activities, as well as an attenuation of excitatory amino acids (EAAs) toxicity of the active ingredients, especially the most active apigenin, from NSTC. Specifically, naringenin, calycosin, gastrodin, caffeic acid, paeoniflorin, and beta-elemene seem to be also pharmacological active substances responsible for the anti-inflammatory effects. Meanwhile, 13-hydroxygemone, gastrodin, and p-hydroxybenzyl alcohol contributed to the attenuation of EAAs toxicity Furthermore, apigenin, naringenin, calycosin, gastrodin, and beta-elemene accelerated the repair of brain ischemic tissue by up-regulating the expression of TGF-beta 1 levels. Conclusions The present study identifies the active ingredients of NSTC and illustrates the underlying mechanism using a combination of network pharmacology, transcriptomics analysis, and pharmacological experiments.</abstract><cop>LONDON</cop><pub>Springer Nature</pub><pmid>33292339</pmid><doi>10.1186/s13020-020-00399-7</doi><tpages>15</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1749-8546
ispartof Chinese medicine, 2020-11, Vol.15 (1), p.1-119, Article 119
issn 1749-8546
1749-8546
language eng
recordid cdi_proquest_miscellaneous_2468675050
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; SpringerNature Journals; PubMed Central Open Access; Web of Science - Science Citation Index Expanded - 2020<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" />; PubMed Central; Springer Nature OA/Free Journals
subjects Acids
Amino acids
Analysis
Antioxidants
Apoptosis
Caffeic acid
Chinese medicine
Ethanol
Excitatory amino acids
FDA approval
Inflammation
Integrative & Complementary Medicine
Ischemia
Laboratory animals
Life Sciences & Biomedicine
Mice
Morphometry
Naoshuantong capsule
Naringenin
Network pharmacology
Neuroprotection
Neuroprotective
Pharmacology
Pharmacology & Pharmacy
Proteins
Science & Technology
Software
Solvents
Stroke
Toxicity
Transforming growth factor-b1
Transforming growth factors
title The study of neuroprotective effects and underlying mechanism of Naoshuantong capsule on ischemia stroke mice
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T00%3A58%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20study%20of%20neuroprotective%20effects%20and%20underlying%20mechanism%20of%20Naoshuantong%20capsule%20on%20ischemia%20stroke%20mice&rft.jtitle=Chinese%20medicine&rft.au=Luo,%20Lvkeng&rft.date=2020-11-17&rft.volume=15&rft.issue=1&rft.spage=1&rft.epage=119&rft.pages=1-119&rft.artnum=119&rft.issn=1749-8546&rft.eissn=1749-8546&rft_id=info:doi/10.1186/s13020-020-00399-7&rft_dat=%3Cgale_proqu%3EA642286986%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2461811547&rft_id=info:pmid/33292339&rft_galeid=A642286986&rft_doaj_id=oai_doaj_org_article_812274ae23d14331871cb3edd2ffdbd5&rfr_iscdi=true